Current drug discovery is dominated by target / cell-based approaches that fails to capture the complexity of biology at organ and organism levels.


At Organ and Organism levels, we remain reliant on animal models and human trials, which contribute to high failure rates, excessive costs, and lengthy timelines. Current drug discovery is not efficient
Current drug discovery failure rate is about 90%, costs more than $2B per drug and takes more than 10 years to get approval.

Phenotypic
Target based


Technology GAP in drug discovery
Current generative AI advancements incapable of handling biological complexities at all scales leading to a technology GAP.
Technology GAP



Organome Platform
Organome:
The first AI organism level model

Trained on multimodal omics data to build the first generative AI platform to simulate biology at all scales

AIVIVO LTD © 2025 All Right Reserved